THERAPY OF CANCER METASTASIS BY SYSTEMIC ACTIVATION OF MACROPHAGES - FROM THE BENCH TO THE CLINIC

被引：49

作者：

FIDLER, IJ

KLEINERMAN, ES

机构：

来源：

RESEARCH IN IMMUNOLOGY | 1993年 / 144卷 / 04期

关键词：

D O I：

10.1016/0923-2494(93)80109-C

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：284 / 287

页数：4

共 15 条

[1] DELIVERY OF LIPOSOME-ENCAPSULATED DRUGS TO MACROPHAGES [J].

ALVING, CR .

PHARMACOLOGY & THERAPEUTICS, 1983, 22 (03) :407-424

[2]

CREAVEN PJ, 1990, J BIOL RESP MODIF, V9, P492

[3]

Dannenberg A.M., 1988, PULMONARY DISEASES D, V3, P1821

[4]

FIDLER IJ, 1985, CANCER RES, V45, P4714

[5] RECOGNITION AND DESTRUCTION OF NEOPLASTIC-CELLS BY ACTIVATED MACROPHAGES - DISCRIMINATION OF ALTERED SELF [J].

FIDLER, IJ ;

SCHROIT, AJ .

BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 948 (02) :151-173

[6]

FIDLER IJ, 1990, CANCER RES, V50, P6130

[7]

FIDLER IJ, 1991, BIOL THERAPY CANCER, P730

[8]

KLEINERMAN E, 1983, J CLIN INVEST, V72, P1

[9] INFLUENCE OF CHEMOTHERAPY ADMINISTRATION ON MONOCYTE ACTIVATION BY LIPOSOMAL MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE IN CHILDREN WITH OSTEOSARCOMA [J].

KLEINERMAN, ES ;

SNYDER, JS ;

JAFFE, N .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (02) :259-267

[10] UNIQUE HISTOLOGICAL-CHANGES IN LUNG METASTASES OF OSTEOSARCOMA PATIENTS FOLLOWING THERAPY WITH LIPOSOMAL MURAMYL TRIPEPTIDE (CGP-19835A LIPID) [J].

KLEINERMAN, ES ;

RAYMOND, AK ;

BUCANA, CD ;

JAFFE, N ;

HARRIS, MB ;

KRAKOFF, IH ;

BENJAMIN, R ;

FIDLER, IJ .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 1992, 34 (04) :211-220

← 1 2 →